Artivion Q1 revenue $97.4M (+17% YoY); nets $7.5M income vs loss; raises FY24 guidance

ARTIVION, INC.

2024-Q1 EPS reported $0.18 revenue$97,431,000

Revenue $97.4M, up 17% GAAP (16% constant currency) vs $83.2M in Q1 2023.
Net income $7.5M ($0.18 diluted EPS) vs net loss ($13.5M) in Q1 2023; non-GAAP net income $2.6M ($0.06 EPS).
Non-GAAP adjusted EBITDA rose 60% to $17.3M from $10.8M in Q1 2023.
Revised FY24 constant-currency revenue growth guidance to 9%-12% (prev 8%-12%); revenue range $386M-$396M.
Tissue processing +26% constant currency YoY; stent grafts +19%; Latin America +22% constant currency.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.